Effects of enzymatic and non-enzymatic antioxidants in diluents on cryopreserved bull epididymal spe

来源 :亚太生殖杂志(英文版) | 被引量 : 0次 | 上传用户:windy_yuan
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To evaluate the supplementation effects of vitamin E, vitamin C, superoxide dismutase (SOD), and catalase to diluents on bull cryopreserved epididymal sperm. Methods: Sperm were retrieved from 20 bull testes and were then supplemented with 0.1 mM vitamin E, 5.0 mM vitamin C, 100.0 IU/mL SOD, and 100.0 μg/mL catalase alone, or in a combination. The control treatment contained no addition. After supplementation, samples were frozen and stored in liquid nitrogen. The sperm parameters including motility, progressive motility, viability, acrosome integrity, plasma membrane integrity, kinematics and DNA damage were evaluated following the thawing process. Results: Vitamin E alone significantly increased the parameters of acrosome and membrane integrity compared to the control treatment (P<0.05). While compared to the control treatment, vitamin C had no improvement effect on sperm characteristics except for membrane integrity. Treatment of vitamin E+vitamin C had a significant improvement in total motility, progressive motility, viability, membrane and acrosome integrity compared to the control and other treatments (P<0.05). Compared to the control treatment, addition of SOD or catalase alone significantly improved the percentages of total motility, progressive motility, viability, membrane and acrosome integrity (P<0.05). Furthermore, SOD+catalase significantly increased total motility, progressive motility, viability, acrosome and membrane integrity characteristics compared to the catalase treatment (P<0.05). Vitamin E alone, vitamin E+vitamin C, and SOD in diluents decreased DNA damages and thereby improved the rate of intact sperm heads. Conclusions: Addition of 100.0 IU/mL SOD alone and 0.1 mM vitamin E+5.0 mM vitamin C, and also 5.0 mM vitamin C+100 μg/mL catalase in a combination improves the quality of cryopreserved bull epididymal sperm and could be used for cryopreservation.
其他文献
2021年免疫治疗的相关临床研究在各个瘤种中继续遍地开花,而在肿瘤放射治疗领域里,除了免疫治疗的更深入研究,临床研究更关注于放疗剂量、分割模式的优化.
新年的钟声刚刚敲响,回首2021,持续的疫情、低靡的经济均不能阻挡研究者前进的脚步,肺癌领域不断公布令人欣喜的研究成果.rn1 早期非小细胞肺癌(non-small-cell lung cancer,NSCLC)治疗进展rn最 新 版 美 国 综 合 癌 症 网 络(National Comprehensive Cancer Network,NCCN)指南对于可手术的ⅠA期NSCLC患者,优先推荐外科手术切除+淋巴结清扫或取样活检[1].近年来,关于早期患者的放射治疗研究层出不穷,但大体均为不劣性研究,对
Objective: To identify healthcare managers\' perspectives on the barriers to implementing cervical length screening to prevent preterm births. Methods: In PhaseⅠ, 10 healthcare managers were interviewed. Phase Ⅱ comprised questionnaire development and d
靶向治疗在恶性血液肿瘤治疗中发挥着重要的作用.药物特异性靶向基因或者蛋白能够通过干扰肿瘤细胞生长和增殖,从而实现对肿瘤的治疗.靶向治疗也经常与传统的化疗,手术治疗和放疗联合使用.但是靶向治疗存在着靶点突变,耐药以及脱靶等问题,还伴随着强烈的副作用.因此,对靶向治疗药物的研发和改进一直是血液肿瘤领域重要的研究方向.近年来,靶向治疗在血液肿瘤治疗中取得显著进步,本文将对近期靶向治疗小分子药物在血液肿瘤中的进展进行回顾.
2021年,胃肠道肿瘤的免疫和分子靶向治疗依然是研究的热点,尤其在胃癌领域,靶免治疗的研究全面开花,免疫检查点抑制剂(immune checkpoint inhibitors,ICI)和抗体偶联药物(antibody-drug conjugate,ADC)及其适应证接连获批,不少新的免疫、靶向药物进入临床研究,相信随着研究的深入,将有更多的胃肠肿瘤患者能够从精准化、个性化的治疗中得到获益.
原发性肝癌是全球性健康难题,其发病率持续上升,已从2010年的第7位上升至2019年的第5位[1-2].其中,肝细胞癌(hepatocellular carcinoma,HCC)是最常见的病理类型,约占90%.本文回顾和总结2021年HCC在局部治疗和系统治疗方面的重要临床研究进展,以期对从事HCC 相关工作的临床医生和科研人员有所帮助.
The pandemic caused by the worldwide spread of the coronavirus,which first appeared in 2019,has been named coronavirus disease 19 (COVID-19).More than 4.5 million deaths have been recorded due to the pandemic caused by severe acute respiratory syndrome co
Objective: To identify factors that determine the uptake of in-vitro fertilization (IVF), and to determine the predicting effect of the identified factors on the uptake of IVF among couples attending fertility clinic at a tertiary health institution in Be
Objective: To study the prevalence and associated factors of recurrent ovarian endometrioma after ovarian cystectomy. Methods: This retrospective study analyzed 303 patients who underwent cystectomy for ovarian endometrioma and had at least a 2-year follo
Klinefelter syndrome represents one of the most common male sex chromosome disorders with a prevalence of 1 out of 500 male newborns[1].
期刊